Non-therapeutic plasma levels in individuals utilizing curcumin supplements in daily life

Maurice A.G.M. Kroon(Amsterdam University Medical Centers), E. Marleen Kemper(Amsterdam University Medical Centers), Jacqueline K. Berbee(Amsterdam University Medical Centers), Eleonora L. Swart(Amsterdam University Medical Centers), Soumia Majait(Amsterdam University Medical Centers), Olaf van Tellingen(Dutch Cancer Society), Hanneke W.M. van Laarhoven(Dutch Cancer Society)
Frontiers in Nutrition
November 30, 2023
10.3389/fnut.2023.1267035
Cited by 14

Related Papers

Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial
|The Lancet Oncology|2015|2.6k
Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs
|Cell|1994|2.3k
Overcoming the blood–brain tumor barrier for effective glioblastoma treatment
|Drug Resistance Updates|2015|1k
Normal viability and altered pharmacokinetics in mice lacking mdr1-type (drug-transporting) P-glycoproteins
|Proceedings of the National Academy of Sciences|1997|941
Limited oral bioavailability and active epithelial excretion of paclitaxel (Taxol) caused by P-glycoprotein in the intestine
|Proceedings of the National Academy of Sciences|1997|884